Skip to content

The effect of PRP on knee osteoarthritis

Comparison of the effectiveness of single and triple doses of platelet-rich plasma injection on articular cartilage thickness, pain, stiffness and physical performance in patients with knee osteoarthritis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20241201063910N1
Enrollment
40
Registered
2025-01-26
Start date
2024-12-21
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee osteoarthritis. Osteoarthritis of knee

Interventions

Intervention 1: Intervention group: One injection of platelet-rich plasma. Intervention 2: Intervention group: Three injections of platelet-rich plasma at one-week intervals.

Sponsors

Mazandaran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: All patients aged 40 to 75 years, regardless of gender, with knee pain (for at least 3 months) and radiological staging according to the Kellgren-Lawrence (KL) system of grades 1, 2, and 3.

Exclusion criteria

Exclusion criteria: KL Grade 4 BMI above 35 Hemoglobin level below 10 Use of medication, physiotherapy, and exercise therapy during the intervention Use of nonsteroidal anti-inflammatory drugs (NSAIDs) and systemic steroids or immunomodulators within the last week and three months after PRP injection Malignancies and poor general condition Use of anticoagulant drugs History of infection/steroid injection/arthroscopy/knee surgery Concomitant back pain Thrombocytopenia Bleeding disorders Knee inflammation and effusion fluid accumulation Osteoarthritis secondary to inflammatory/metabolic diseases Knee instability

Design outcomes

Primary

MeasureTime frame
Pain score. Timepoint: At the beginning of the study and 3 and 6 months after injection. Method of measurement: Visual Analogue Scale.;Performance. Timepoint: At the beginning of the study and 3 and 6 months after injection. Method of measurement: WOMAC questionaire.

Secondary

MeasureTime frame
Articular cartilage thickness. Timepoint: At the beginning of the study and 6 months after injection. Method of measurement: Ultrasound machine.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHajar Salimi

Mazandaran University of Medical Sciences

HJR.SALIMI93@GMAIL.COM+98 11 3336 6552

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026